GC Cell Corporation (KOSDAQ:144510)
23,750
-650 (-2.66%)
Apr 30, 2026, 3:30 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 356.89 billion as of April 30, 2026. Its market cap has increased by 16.42% in one year.
Market Cap
356.89B
Enterprise Value
439.64B
Revenue
165.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
23,750.00
Market Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 356.89B, a decrease of -29.70%. That is a compound annual growth rate of -3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 366.66B | -1.81% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Corp. | 643.80B |
| SillaJen | 502.10B |
| Genomictree | 456.92B |
| Helixmith | 412.12B |
| Anterogen.Co.,Ltd. | 372.23B |
| BINEX | 370.71B |
| HLB Therapeutics | 321.66B |
| Bioneer | 283.14B |